Published in Toxicol Sci on May 25, 2009
ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol (2010) 2.15
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev (2011) 1.14
Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways. PLoS One (2011) 1.09
Identification and characterization of adverse effects in 21st century toxicology. Toxicol Sci (2012) 0.87
Accelerating the development of 21st-century toxicology: outcome of a Human Toxicology Project Consortium workshop. Toxicol Sci (2011) 0.86
High throughput toxicity screening and intracellular detection of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
FutureTox II: in vitro data and in silico models for predictive toxicology. Toxicol Sci (2015) 0.78
Effects of engineered nanomaterials on plants growth: an overview. ScientificWorldJournal (2014) 0.76
Biomembrane disruption by silica-core nanoparticles: effect of surface functional group measured using a tethered bilayer lipid membrane. Biochim Biophys Acta (2013) 0.75
In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms. Nanomedicine (2013) 0.75
Toxic potential of materials at the nanolevel. Science (2006) 19.24
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Toxicology. Transforming environmental health protection. Science (2008) 7.50
Safe handling of nanotechnology. Nature (2006) 7.25
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci (2003) 6.95
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol (2005) 6.04
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci (2003) 5.73
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Nanotechnology safety concerns revisited. Toxicol Sci (2007) 2.41
Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci (2001) 2.09
Toxicity testing in the 21st century: bringing the vision to life. Toxicol Sci (2008) 2.06
Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci U S A (2008) 2.04
Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02
How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci (2008) 1.65
Nanotechnology. Can high-speed tests sort out which nanomaterials are safe? Science (2008) 1.59
American Chemical Society meeting. Nanomaterials show signs of toxicity. Science (2003) 1.43
The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol (2009) 1.38
Concepts of nanoparticle dose metric and response metric. Environ Health Perspect (2007) 1.12
Toxicology. Transforming environmental health protection. Science (2008) 7.50
Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect (2012) 3.17
Improving the human hazard characterization of chemicals: a Tox21 update. Environ Health Perspect (2013) 2.95
Systematic review and evidence integration for literature-based environmental health science assessments. Environ Health Perspect (2014) 2.05
A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol (2003) 1.36
NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. Toxic Rep Ser (2007) 1.30
Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds". Environ Health Perspect (2005) 1.29
The Office of Health Assessment and Translation: a problem-solving resource for the National Toxicology Program. Environ Health Perspect (2011) 1.20
Bisphenol A: where to now? Environ Health Perspect (2009) 1.18
A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program. Reprod Toxicol (2013) 1.11
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis. Environ Health Perspect (2015) 1.05
IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03
Consortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol A. Environ Health Perspect (2012) 1.02
Toxicity characterization of environmental chemicals by the US National Toxicology Program: an overview. Int J Hyg Environ Health (2003) 0.99
Bisphenol A, Bisphenol S, and 4-Hydroxyphenyl 4-Isoprooxyphenylsulfone (BPSIP) in Urine and Blood of Cashiers. Environ Health Perspect (2015) 0.98
alpha 2u-globulin nephropathy and renal tumors in national toxicology program studies. Toxicol Pathol (2007) 0.97
Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice. Toxicol Sci (2004) 0.97
Commentary: update on animal models for NTP studies. Toxicol Pathol (2009) 0.95
Implementing systematic review at the National Toxicology Program: status and next steps. Environ Health Perspect (2013) 0.92
Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies. Environ Health Perspect (2008) 0.90
The National Toxicology Program Web-based nonneoplastic lesion atlas: a global toxicology and pathology resource. Toxicol Pathol (2014) 0.88
Intersection of systematic review methodology with the NIH reproducibility initiative. Environ Health Perspect (2014) 0.86
Prioritizing Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using ToxCast™ High-Throughput Data. Environ Health Perspect (2016) 0.82
Inhalation toxicology and carcinogenesis studies of propylene glycol mono-t-butyl ether in rats and mice. Toxicology (2004) 0.81
Comparison of chronic toxicity and carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in 2-year bioassays in female Sprague-Dawley rats. Mol Nutr Food Res (2006) 0.81
A review of evidence from short-term studies leading to the prediction that diazoaminobenzene (1,3-diphenyltriazine) is a carcinogen. J Appl Toxicol (2005) 0.80
Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research. Environ Health Perspect (2015) 0.78
Acrylonitrile is a multisite carcinogen in male and female B6C3F1 mice. Toxicol Sci (2002) 0.78
Influence of Helicobacter hepaticus infection on the chronic toxicity and carcinogenicity of triethanolamine in B6C3F1 mice. Toxicol Pathol (2008) 0.78
Comment on "On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens". Environ Health Perspect (2017) 0.75
DETERMINING DISEASE CAUSALITY FROM EXPERIMENTAL TOXICOLOGY STUDIES. J Law Policy (2005) 0.75
Toxicity and carcinogenicity of methyl isobutyl ketone in F344N rats and B6C3F1 mice following 2-year inhalation exposure. Toxicology (2007) 0.75
Influence of functional group substitutions on the carcinogenicity of anthraquinone in rats and mice: analysis of long-term bioassays by the National Cancer Institute and the National Toxicology Program. J Toxicol Environ Health B Crit Rev (2005) 0.75
Micronucleus induction in mice exposed to diazoaminobenzene or its metabolites, benzene and aniline: implications for diazoaminobenzene carcinogenicity. Mutat Res (2002) 0.75
Toxicology and carcinogenesis studies of dipropylene glycol in rats and mice. Toxicology (2004) 0.75